English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52889914    Online Users :  795
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu c"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 451-475 of 881  (36 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-12-02T02:34:30Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏 2020-11-27T08:14:24Z Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma Hsiao S.-M.;Chen C.-A.;Hsu C.;Lin H.-H.;Chang-Yao Hsieh;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; Hsu C.; Lin H.-H.; CHANG-YAO HSIEH; Wei L.-H.
臺大學術典藏 2020-11-19T03:43:04Z HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity Huang C.-L.; Hsu H.-C.; PO-HUANG LEE; Wang S.-J.; Cheng A.-L.; Hsu C.; Hsu C.;Huang C.-L.;Hsu H.-C.;Po-Huang Lee;Wang S.-J.;Cheng A.-L.
臺大學術典藏 2020-11-19T03:42:56Z Low-dose thalidomide treatment for advanced hepatocellular carcinoma Hsu C.;Chen C.-N.;Chen L.-T.;Wu C.-Y.;Yang P.-M.;Lai M.-Y.;Po-Huang Lee;Cheng A.-L.; Hsu C.; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; PO-HUANG LEE; Cheng A.-L.
臺大學術典藏 2020-11-19T03:19:32Z Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice Lo S.; Yuan S.-S.F.; Hsu C.; Cheng Y.-J.; Chang Y.-F.; Hsueh H.-W.; PO-HUANG LEE; Hsieh Y.-C.
臺大學術典藏 2020-11-11T08:19:58Z Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data Campbell B.C.V.; Ma H.; Ringleb P.A.; Parsons M.W.; Churilov L.; Bendszus M.; Levi C.R.; Hsu C.; Kleinig T.J.; Fatar M.; Leys D.; Molina C.; Wijeratne T.; Curtze S.; Dewey H.M.; Barber P.A.; Butcher K.S.; De Silva D.A.; Bladin C.F.; Yassi N.; Pfaff J.A.R.; Sharma G.; Bivard A.; Desmond P.M.; Schwab S.; Schellinger P.D.; Yan B.; Mitchell P.J.; Serena J.; Toni D.; Thijs V.; Hacke W.; Davis S.M.; Donnan G.A.; Donnan G.A.; Davis S.M.; Parsons M.W.; Mitchell P.J.; Desmond P.M.; Oxley T.; Wu T.Y.; Shah D.; Zhao H.; Rodrigues E.; Salvaris P.; Alemseged F.; Ng F.; Williams C.; Ng J.-L.; Tu H.T.-H.; McDonald A.; Jackson D.; Tsoleridis J.; McCoy R.; Pesavento L.; Weir L.; Kleinig T.J.; Patel S.; Harvey J.; Mahadevan J.; Cheong E.; Balabanski A.; Waters M.; Drew R.; Cranefield J.; Mackey E.; Celestino S.; Low E.; Dewey H.M.; Bladin C.F.; Loh P.S.; Choi P.M.; Coote S.; Frost T.; Hogan K.; Ding C.; McModie S.; Zhang W.W.; Kyndt C.; Moore A.; Ross Z.; Liu J.; Miteff F.; Levi C.R.; Ang T.; Spratt N.; Garcia-Esperon C.; Kaauwai L.; Phan T.G.; Ly J.; Singhal S.; Clissold B.; Wong K.; Krause M.; Day S.; Sturm J.; O'Brian B.; Grimley R.; Simpson M.; Lee-Archer M.; Brodtmann A.; Coulton B.; Young D.; Wong A.A.; Muller C.; Field D.K.; Vallat W.; Maxwell V.; Bailey P.; Sabet A.; Mishra S.; Tan M.; George K.; Barber P.A.; Zhao L.; Meretoja A.; Tatlisumak T.; Sibolt G.; Tiainen M.; Koivu M.; Aarnio K.; Virta J.; Kasari O.; Eirola S.; Sun M.C.; Chen T.C.; Chuang C.S.; Chen Y.Y.; Lin C.M.; Ho S.C.; Hsiao P.M.; Tsai C.H.; Huang W.S.; Yang Y.W.; Huang H.Y.; Wang W.C.; Liu C.H.; Lu M.K.; Lu C.H.; Kung W.L.; Jiang S.K.; Wu Y.H.; Huang S.C.; Tseng C.H.; Tseng L.T.; Guo Y.C.; Lin D.; Hsu C.T.; Kuan C.W.; Hsu J.P.; Tsai H.T.; Suzuki M.; Sun Y.; Chen H.F.; Lu C.J.; Lin C.H.; Huang C.C.; Chu H.J.; Lee C.Y.; Chang W.H.; Lo Y.C.; Hsu Y.T.; CHIH-HAO CHEN; Sung P.S.; Ysai C.L.; Jeng J.S.; Tang S.C.; Tsai L.K.; Yeh S.J.; Lee Y.C.; Wang Y.T.; Chung T.C.; Hu C.J.; Chan L.; Chiou Y.W.; Lien L.M.; Yeh H.L.; Yeh J.H.; Chen W.H.; Lau C.L.; Chang A.; Lee I.Y.; Huang M.Y.; Lee J.T.; Peng G.S.; Lim J.C.; Hsu Y.D.; Lin C.C.; Cheng C.A.; Yen C.H.; Yang F.C.; Hsu C.H.; Sung Y.F.; Tsai C.K.; Tsai C.L.; Lee A.; Hankey G.; Blacker D.; Gerraty R.; Chen C.-I.; Hsu C.-S.; Cowley E.; Sallaberger M.; Snow B.; Kolbe J.; Stark R.; King J.; Macdonnell R.; Attia J.; D'Este C.; Bernhardt J.; Carey L.; Cadilhac D.; Anderson C.; Howells D.; Barber A.; Connelly A.; Macleod M.; O'Collins V.; Wilson W.; Macaulay L.; Bluhmki E.; Eschenfelder C.; Ringleb P.; Wahlgren N.; Wardlaw J.; Oppenheim C.; Lees K.R.; Kaste M.; von Kummer R.; Chatellier G.; Laage R.; Nu?ez X.; Ehrenkrona C.; Svenson A.-S.; Cove L.; Niederkorn K.; Gruber F.; Kapeller P.; Mikulik R.; Mas J.-L.; Berrouschot J.; Sobesky J.; K?hrmann M.; Steiner T.; Kessler C.; Dziewas R.; Poli S.; Althaus-Knaurer K.; Bovi P.; Rodriguez A.L.; Arenillas J.F.; Muir K.; Veltkamp R.; Dixit A.; Muddegowda G.; Kala L.; De Silva D.A.; Butcher K.S.; Byrnes G.; Peeters A.; Chalk J.B.; Fink J.N.; Kimber T.E.; Schultz D.; Hand P.J.; Frayne J.; Tress B.M.; McNeil J.; Burns R.; Johnston C.; Williams M.; EXTEND, ECASS-4; EPITHET Investigators
臺大學術典藏 2020-11-02T02:04:37Z Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; MING-SHIANG WU; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L.
臺大學術典藏 2020-10-23T03:49:06Z Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients with Severe Illnesses? Wu E.-T.; Hwu W.-L.; Chien Y.-H.; Hsu C.; Chen T.-F.; Chen N.-Q.; Chou H.-C.; PO-NIEN TSAO; Fan P.-C.; Tsai I.-J.; Lin S.-P.; Hsieh W.-S.; Chang T.-M.; Chen C.-N.; Lee C.-H.; Chou Y.-Y.; Chiu P.-C.; Tsai W.-H.; Hsiung H.-C.; Lai F.; Lee N.-C.
臺大學術典藏 2020-10-20T01:45:47Z Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies TAI-CHUNG HUANG; Ko B.-S.; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.
臺大學術典藏 2020-09-30T08:49:47Z Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis Cheng M.-F.; YEN-WEN WU; Liu K.-L.; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏 2020-09-29T06:53:04Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer Kuo S.-H.; Cheng A.-L.; Tien Y.-W.; Yeh K.-H.; Hsu C.-H.; Hsu C.; Wu H.; Guo J.-C.; TING-CHUN KUO; Yang S.-H.
臺大學術典藏 2020-09-29T01:47:44Z Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers Yeh K.-H.; Cheng A.-L.; Yang J.C.-H.; Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN; Hu F.-C.
臺大學術典藏 2020-09-23T07:36:15Z Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis Mei-Fang Cheng;Wu Y.-W.;Liu K.-L.;Yen R.-F.;Wu Y.-M.;Hsu C.;Chang Y.-T.;Tzen K.-Y.;Wang H.-P.; MEI-FANG CHENG; Wu Y.-W.; Liu K.-L.; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏 2020-09-23T06:22:40Z Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate Hsu C.; Hong R.-L.; Tzen C.-Y.; Jeng Y.-M.; RUOH-FANG YEN; Lin C.-H.; Lin C.-H.;Ruoh-Fang Yen;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Hong R.-L.
臺大學術典藏 2020-09-23T06:22:31Z Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis Cheng M.-F.; Wu Y.-W.; Liu K.-L.; RUOH-FANG YEN; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏 2020-09-22T07:39:54Z Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏 2020-09-22T07:39:51Z Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.
臺大學術典藏 2020-09-22T07:39:50Z Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏 2020-08-14T03:15:33Z Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies Chen B.-B.; I-LUN SHIH; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C.
臺大學術典藏 2020-08-14T03:15:30Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-08-13T06:34:06Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C.
臺大學術典藏 2020-08-13T06:34:05Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Yang T.-Y.; Yang C.-H.; JIN-YUAN SHIH; Chen K.-C.
臺大學術典藏 2020-08-13T06:33:59Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T06:35:54Z Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.; Kuo S.-H.; Yang C.-H.; Kuo S.-H.;Yang C.-H.;Chong-Jen Yu;Hsu C.;Cheng A.-L.;Yang P.-C.
臺大學術典藏 2020-08-12T06:35:50Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.;Yang C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu C.;Yang P.-C.; Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.

Showing items 451-475 of 881  (36 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page